We are live on ! Find out more

14 hedge funds and large institutions have $4.07M invested in Daxor in 2026 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

700% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 1

185% more capital invested

Capital invested by funds: $1.43M → $4.07M (+$2.64M)

75% more funds holding

Funds holding: 814 (+6)

6.34% more ownership

Funds ownership: 2%8.34% (+6.3%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
14
Holders Change
+6
Holders Change %
+75%
% of All Funds
0.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
Reduced
3
Closed
1
Calls
Puts
Net Calls
Net Calls Change

DXR Hedge Fund Activity: Q1 2026 in Review

14 of the 8,139 institutional investors tracked by Wall St. Rank reported a position in Daxor (DXR) for Q1 2026, worth a combined $4.07M — up 185% from $1.43M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new DXR positions and 1 closed out — a net gain of 7 holders — while 0 added to existing stakes and 3 trimmed.

The largest buyer was Thompson Siegel & Walmsley, opening a new position worth an estimated $2.83M. The largest seller was Renaissance Technologies, cutting an estimated $2.56K.

  • 14 institutional investors held Daxor (DXR) as of Q1 2026, up from 8 in Q4 2025.
  • Funds reported $4.07M of Daxor stock for Q1 2026, up 185% quarter-over-quarter.
  • 8 funds opened new Daxor positions in Q1 2026 and 1 closed out, a net change of +7 holders.
  • The largest Daxor buyer in Q1 2026 was Thompson Siegel & Walmsley, an estimated $2.83M added.
  • The largest Daxor seller in Q1 2026 was Renaissance Technologies, an estimated $2.56K sold.

Based on aggregated 13F filings for Q1 2026.